January 31, 2018 / 6:37 PM / 17 days ago

BRIEF-Nemaura Announces Positive Results For Its Sugarbeat European Clinical Program

Jan 31 (Reuters) - Nemaura Medical Inc:

* NEMAURA ANNOUNCES POSITIVE RESULTS FOR ITS SUGARBEAT® EUROPEAN CLINICAL PROGRAM

* NEMAURA MEDICAL - SUGARBEAT IS EXPECTED TO LAUNCH IN UK, FOLLOWED BY OTHER TERRITORIES UPON ACHIEVING CE APPROVAL, WHICH IS ANTICIPATED IN COMING MONTHS

* NEMAURA MEDICAL INC - ADDITIONAL CLINICAL STUDIES ARE PLANNED FOR SUGARBEAT FOR FDA APPROVAL IN U.S.

* NEMAURA MEDICAL - ADDITIONAL CLINICAL STUDIES ARE PLANNED FOR SUGARBEAT FOR FDA APPROVAL IN U.S., AND FOR USE OF SUGARBEAT IN CRITICAL CARE SETTINGS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below